Gateway 2011: 3M Drug Delivery Systems - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2011: 3M Drug Delivery Systems



Your online Gateway to 3M Drug Delivery Systems in 2011

3M Center, Bldg. 275-3E-10
St. Paul, MN 55144
1-800-643-8086
www.3M.com/DDS


Don't miss 3M Drug Delivery Systems at Respiratory Drug Delivery, May 3-6, 2011 in Berlin, Germany

About 3M Drug Delivery Systems

For more than 50 years, pharmaceutical companies worldwide have looked to 3M Drug Delivery
Systems for ingenious inhalation (dry powder inhaler and metered-dose inhaler) and transdermal (microneedle
and drug-in-adhesive) solutions to help their products meet the needs of the market. With proven international
success in technology, development, manufacturing and regulatory, partnering with 3M helps ensure critical
speed to market and the technical success of your project.

Join Us at RDD

We’ll be showcasing 3M’s Drug Powder Inhalers as well as a variety of other inhalation drug delivery devices
and components.
We’re also offering a DPI: Design for Manufacturing and Scale-Up (DFMSU) workshop as well as several
poster presentations highlighting the most performance data from our new Dry Powder Inhalers. See “New Dry
Powder Inhaler Data at RDD Europe” below to learn more.
Visit us at the conference or set up a meeting to find out how our depth of resources can help enable your next
project’s success.

 

New Products
and Releases
New Whitepapers

RDD International Symposium

3M Conix™ Dry Powder Inhalers
New Dry Powder Inhaler Data at RDD Europe  

3M™ Taper Dry Powder Inhaler

 

 

 

 

 



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here